Onyx Biotec Limited — Others, 29-01-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Onyx Biotec Ltd. has announced a board meeting to discuss its financial results for the quarter and half-year ended December 31, 2024. The company confirmed that it is not subject to corporate governance provisions as outlined in the SEBI regulations due to its paid-up equity share capital and net worth being below specified thresholds. This status may provide Onyx with operational flexibility, potentially allowing for increased focus on growth strategies without the constraints of corporate governance compliance. Investors may view this as a positive outlook, as it may enable the company to allocate resources more effectively.